Active

JUNCTION PHARMA LIMITED Financials

Company number
11669313Copy
Copy
Registered office
4 Batley Road, Heckmondwike WF16 9NE
Incorporated
09/11/2018

Company snapshot

Status
Active
Employees
7 (2025)
Latest financial data
2025
Accounts type
Unaudited abridged

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2025.

Net Assets

£67.86K2025
166.07%vs 2024

2024: £25.50K

Total Assets

£538.91K2025
-34.86%vs 2024

2024: £827.31K

Cash in Bank

£101.39K2025
-75.62%vs 2024

2024: £415.87K

Total Liabilities

£471.05K2025
-41.25%vs 2024

2024: £801.80K

Employees

72025
0vs 2024

2024: 7

In 2025, JUNCTION PHARMA LIMITED reported net assets of £67.86K. The same filing shows total assets of £538.91K, cash in bank of £101.39K and total liabilities of £471.05K. Reported headcount was 7 in 2025. Total Liabilities fell from £801.80K in 2024 to £471.05K in 2025 (-41.25%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£67.86K2025
166.07%from £25.50K in 2024

Year-on-year change

Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.

3-year financial trend (2023–2025)

How the figures JUNCTION PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.

Net Assets

£17.98K2023£67.86K2025
+277%vs 2023

+94.3% a year compound (CAGR)

Cash in Bank

£371.62K2023£101.39K2025
-72.7%vs 2023

-47.8% a year compound (CAGR)

Total Assets

£787.78K2023£538.91K2025
-31.6%vs 2023

-17.3% a year compound (CAGR)

Total Liabilities

£769.80K2023£471.05K2025
-38.8%vs 2023

-21.8% a year compound (CAGR)

Employees

4202372025
+75%vs 2023+3

Biggest increase

Net Assets+277%

£17.98K in 2023 to £67.86K in 2025

Biggest decrease

Cash in Bank-72.7%

£371.62K in 2023 to £101.39K in 2025

JUNCTION PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in net assets, pointing to a strengthening balance sheet, set against a fall in cash in bank, pointing to a tighter cash position. See the full year-by-year figures.

Ratios from the filed figures

Calculated from JUNCTION PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
12.59%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
87.41%2025
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Cash to liabilities
21.52%2025
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Cash to total assets
18.81%2025
Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for JUNCTION PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20212022202320242025
Net Assets£83.73K83.73K17.98K25.50K67.86K
Total Assets£250.77K564.84K787.78K827.31K538.91K
Cash in Bank£93.57K93.57K371.62K415.87K101.39K
Total Liabilities£481.10K481.10K769.80K801.80K471.05K
Employees00477

JUNCTION PHARMA LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for JUNCTION PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.

JUNCTION PHARMA LIMITED reported net assets of £67.86K for 2025. That compares with £25.50K in 2024, a change of 166.07%.

JUNCTION PHARMA LIMITED reported total assets of £538.91K for 2025. That compares with £827.31K in 2024, a change of -34.86%.

JUNCTION PHARMA LIMITED reported cash in bank of £101.39K for 2025. That compares with £415.87K in 2024, a change of -75.62%.

JUNCTION PHARMA LIMITED reported 7 employees in 2025, compared with 7 in 2024.

Between 2023 and 2025, JUNCTION PHARMA LIMITED's net assets rose by 277%, cash in bank fell by 72.7%, total assets fell by 31.6% and total liabilities fell by 38.8%. Net assets compounded at 94.3% a year across the two years to 2025, from £17.98K to £67.86K. Reported headcount went from 4 in 2023 to 7 in 2025 (+3).

Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.